Nab-PCE vs PC for MM After Failure of Anti-PD-1

Clinical trial NCT03917069 · UNKNOWN

Trial details

NCT number: NCT03917069
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2019-03-23
Primary completion: 2021-09-30
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.